bioRxiv Science⌕ Search

Biology subjects

Perez-Tremble, R.

Publications and source records attributed to Perez-Tremble, R..

2 recordsLinked to original sources

Mechanisms controlling the deposition and dynamics of histone variant H2BE

Histone variants shape chromatin structure and gene regulation and their deposition and localization in chromatin are tightly controlled. H2BE is the only known widely expressed mammalian H2B variant and localizes to transcription start sites to control chromatin accessibility and cognitive function. However, the mechanisms governing H2B variant incorporation into chromatin remain unclear. Here, we define the regulatory framework controlling H2BE incorporation, localization, and eviction in neuronal chromatin. We identify the BAF remodeling complex and the transcription factor SP1 as key drivers of H2BE deposition at specific genomic loci. We further show that FACT maintains H2BE enrichment at transcription start sites by preventing its distribution into gene bodies, while the histone chaperone NAP1L4 mediates H2BE eviction from chromatin. Comparative analysis with H2A.Z reveals that BAF, SP1 and NAP1L4 exert H2BE-specific functions, while FACT functions more broadly across histone variants. Finally, we define the H2BE-dependent transcriptional effects of it chaperones. Together, these findings uncover the first chaperones governing H2B variant incorporation and define a highly complex mechanism responsible for H2BE regulation in chromatin. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/719605v1_ufig1.gif" ALT="Figure 1"> View larger version (36K): org.highwire.dtl.DTLVardef@199fd10org.highwire.dtl.DTLVardef@b561c1org.highwire.dtl.DTLVardef@24ef4corg.highwire.dtl.DTLVardef@da8152_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIThe BAF complex controls H2BE incorporation. C_LIO_LISP1 promotes locus-specific incorporation of H2BE. C_LIO_LIFACT prevents H2BE accumulation in genic regions. C_LIO_LINAP1L4 mediates eviction of H2BE from chromatin. C_LI

genetics↗

Anionic lipids modulate mRNA-lipid nanoparticle immunogenicity and confer protection in a mouse model of multiple sclerosis

The modularity of mRNA-lipid nanoparticle (mRNA-LNP) platforms has enabled their rapid adaptation from infectious disease vaccines to emerging applications in immune-mediated disorders. However, extending mRNA-LNPs to autoimmune and inflammatory diseases requires precise control over immune cell targeting and immunogenicity. Here, we systematically investigate how incorporating anionic lipids into LNPs modulates both immune cell tropism and innate immune activation. Using a library of 40 distinct LNP formulations, we demonstrate that anionic lipids enhance mRNA delivery to splenic dendritic cells, reduce early cellular markers of adjuvant activity and tune cytokine responses in a lipid-dependent manner. We identify formulations that retain pro-inflammatory adjuvant activity and others that promote tolerogenic responses. A lead formulation containing the anionic lipid DOPG selectively dampens innate activation and induces IL-10 production. When encoding the myelin antigen MOG35-55, this LNP suppresses disease in a mouse model of multiple sclerosis, reducing neuroinflammation, T cell infiltration, and maintaining myelin morphology. These findings establish a framework for designing immune-targeted mRNA-LNPs with tunable immunogenicity and promote the development of antigen-specific tolerizing immunotherapies for autoimmune disease.

bioengineering↗